Antibiotic Therapy Versus Appendectomy for Acute Appendicitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00135603|
Recruitment Status : Completed
First Posted : August 26, 2005
Last Update Posted : February 12, 2009
|Condition or disease||Intervention/treatment|
|Appendicitis||Drug: amoxicillin/clavulanate potassium Procedure: appendectomy|
Appendectomy is the most frequent intra-abdominal operation performed, accounting for the majority of admissions in a general surgery unit. Appendectomy has always been considered the cornerstone in the treatment of acute appendicitis.Nevertheless, the idea of a conservative treatment using antibiotics is not that recent. Current practices have proven the efficiency of antibiotic therapy in treating certain infectious abdominal conditions including: appendicular mass with or without periappendicular abscess and acute diverticulitis. This success has prompted the researchers to consider the exclusive use of antibiotic therapy in the treatment of non complicated appendicitis.
In patients with clinical suspicion of acute appendicitis (localized abdominal tenderness, inflammatory reaction...etc) a CT scan will be performed to confirm the diagnosis of non complicated appendicitis. This diagnosis is confirmed on the CT in the absence of any sign of either localized peritonitis, and/or perforation (extraluminal gas, appendicular abscess, or phlegmon).
After a thorough explanation of this study, the patient will be obliged to sign a written consent. Patients will be randomly assigned to either one of the two therapeutic modalities : an appendectomy,or an antibiotic treatment consisting of amoxicillin and clavulanate potassium.
This therapy will be continued until the normalisation of leucocytic count and C reactive protein are achieved. In order to demonstrate equivalent conclusive results comparing the two treatment modalities, the statistical consultant estimated the inclusion of at least 200 patients in the study. However, after considering the possible loss of a number of patients following their inclusion for a variety of reasons, it was decided that a total of 250 patients will be enrolled.
Rate of intra abdominal infections in both therapeutic strategies is the first endpoint to be compared. Duration of pain, diet, hospitalisation, absence from work will also be compared. In the group of patients treated by antibiotics, the rate of persistant and recurrent appendicitis after treatment will be evaluated. Recurrent appendicitis is not considered a complication as long as the recurrence of the appendicitis is uncomplicated. During the followup period of one year, long-term complications will be observed including: abdominal hernia, adhesive intestinal occlusion, and others.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||243 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Prospective Randomized Multicentric Trial Comparing Amoxicillin/Clavulanate Potassium Therapy to Appendectomy for Acute Non Complicated Appendicitis|
|Study Start Date :||February 2004|
|Primary Completion Date :||February 2008|
|Study Completion Date :||December 2008|
Active Comparator: A
appendectomy, actual usual treatment
ablation of the appendix by laparotomy or laparoscopy
Active Comparator: B
Drug: amoxicillin/clavulanate potassium
1 gramme, 3 times a day, intra venous initially and then orally for one or two weeks
- rate of intra abdominal infections in both therapeutic strategies [ Time Frame: 30 days ]
- duration of pain [ Time Frame: 30 days ]
- duration of hospitalisation [ Time Frame: 30 days ]
- duration of absence from work [ Time Frame: 30 days ]
- rate of wound infection [ Time Frame: 30 days ]
- recurrence of appendicitis [ Time Frame: 12 months ]
- rate of abdominal hernia [ Time Frame: 12 months ]
- rate of adhesive intestinal occlusion [ Time Frame: 12 months ]
- cost [ Time Frame: 30 days and 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00135603
|Antoine Béclère Hospital - Department of Surgery|
|Clamart, France, 92141 cedex|
|Henri Mondor Hospital|
|Creteil, France, 94|
|Hotel Dieu Hospital, Department of Digestive Surgery|
|Paris, France, 75004|
|Cochin Hospital, Department of Digestive Surgery|
|Paris, France, 75014|
|Lariboisière Hospital, Department of Digestive Surgery|
|Paris, France, 75475|
|Principal Investigator:||Corinne Vons, MD,PhD||Assistance Publique - Hôpitaux de Paris|